Amicus Therapeutics, Inc. (FOLD)
14.37
+0.04
(+0.28%)
USD |
NASDAQ |
Feb 27, 16:00
14.36
-0.01
(-0.07%)
After-Hours: 20:00
Amicus Therapeutics Research and Development Expense (Annual) : 135.84M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| BioMarin Pharmaceutical, Inc. | 700.97M |
| CorMedix, Inc. | 3.942M |
| Krystal Biotech, Inc. | 52.32M |
| MannKind Corp. | 66.35M |
| Keros Therapeutics, Inc. | 173.63M |